The authors of this study demonstrated that mutant TP53 was sufficient to drive immune escape in mouse models of medulloblastoma and DIPG and that this immunosuppression was dependent on TP53-mediated down-regulation of MHC-I. Here, TP53 is linked to diffuse intrinsic pontine glioma.